4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-026617
CEO sold 6,770 shares at $49.21 ($333,152)
- CEO acquired 15,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2020-04-29 | Option exercise | +15,625 | 18,579 | D | ||
| DAVIS STEPHEN CEO | 2020-04-30 | Sale | −6,770 | $49.21 | $333,152 | 11,809 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2020-04-29 | Option exercise · Restricted Stock Units | −15,625 | 46,875 | D | ||
| Open-market sales · 6,770 sh · avg $49.21 · $333,152 | |||||||
Loading xslF345X03/doc4.xml…